Clinical trial
Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of…
NCT00023010 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00023010 |
|---|---|
| Title | Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial) |
| Official title | Follow-Up of a Phase-I Gene Therapy Trial of Patients With Leukocyte Adherence Deficiency |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Leukocyte Adhesion Deficiency Syndrome |
| Enrollment | 2 |
| Start date | Aug 15, 2001 |
| Completion | Dec 13, 2010 |
| First posted | Aug 20, 2001 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: